EBOVAC2

Development of a prophylactic Ebola vaccine using an heterologous prime-boost regimen: phase II

keywords: IMI project Infectious diseases Ebola and related diseases Vaccines Ebola+ Conducting clinical trials

Project website
http://www.ebovac2.com/
Start date
2014-12-01
End date
2021-05-31
Types
IMI project
Main contact
Macaya Douoguih
Email
-
Affiliation
Janssen Vaccines & Prevention B.V
Business Address
The Netherlands
Business Phone Number
-
Study Datasets